SEC Info - Kanin Lovers Jill - ‘4’ for 6/23/05 re: Alpharma Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KANIN LOVERS JILL

(Last)

(First)

(Middle)

31 WALLACKS LANE

(Street)

STAMFORD

06831

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ALPHARMA INC [ ALO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
6/23/05

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	$0 ⁽¹⁾	6/23/05		A		5,000		⁽²⁾	⁽³⁾	Common Stock A	5,000	$0	10,000	D

Explanation of Responses:

(1) Each Restricted Stock Unit represents the right to receive one share of the Issuer's Class A Common Stock, for no additional consideration, upon the vesting of such Restricted Stock Unit, all in accordance with the terms and conditions of the Restricted Stock Unit Award Agreement, dated as of the date of the grant between the Reporting Person and the Issuer. For informational purposes only , the closing price of the Issuer's Class A Common Stock on June 23, 2005 was $14.39.

(2) Restricted Stock Units do not vest until twelve months following the Reporting Persons retirement from the Issuer's Board of Directors (the "Board"). Subject to all applicable federal, state and local laws regarding the deferral of director compensation, the Reporting Person may elect to defer receipt of the Class A Common Stock by making an election, in accordance with the Issuer's Amended and Restated Deferred Compensation Plan.

(3) Restricted Stock Units do not have an expiration date, but they are subject to forferture if the Reporting Person resigns from the Board, subject to the terms and conditions of the Restricted Stock Unit Award Agreement.

	By: Marie Amerasinghe, V.P. For: Jill Kanin-Lovers	6/27/05
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Code:
A	Grant, award or other acquisition pursuant to Rule 16b-3(d).

Kanin Lovers Jill – ‘4’ for 6/23/05 re: Alpharma Inc.

On: Monday, 6/27/05, at 2:04pm ET · For: 6/23/05 · As: Director · Accession #: 730469-5-59 · File #: 1-08593

Previous ‘4’: ‘4’ on 4/20/05 for 6/14/04 · Next: ‘4’ on 10/4/05 for 9/30/05 · Latest: ‘4’ on 5/30/17 for 5/25/17

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

‘4’ — Statement of Changes in Beneficial Ownership of Securities by an Insider — edgardoc.xml/2.2